Advances in specific immunotherapy
- 1 October 1992
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 22 (10) , 889-896
- https://doi.org/10.1111/j.1365-2222.1992.tb02061.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 1990
- Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extractJournal of Allergy and Clinical Immunology, 1990
- Responses to ragweed-pollen nasal challenge before and after immunotherapyJournal of Allergy and Clinical Immunology, 1989
- The effect of preseasonal immunotherapy on the production of histamine-refeasing factor (HRF) by mononuclear cells from patients with seasonal asthma: Results of a double-blind, placebo-controlled, randomized studyJournal of Allergy and Clinical Immunology, 1989
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extractJournal of Allergy and Clinical Immunology, 1989
- Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract II. Prediction of efficacy of immunotherapyJournal of Allergy and Clinical Immunology, 1988
- Does the effect of immunotherapy last after termination of treatment?Allergy, 1988
- Diagnosis and Immunotherapy of Mould AllergyAllergy, 1986
- Clinical and immunologic evaluation of tyrosine-adsorbed extract: A double-blind placebo-controlled trialJournal of Allergy and Clinical Immunology, 1984
- House dust mite hyposensitizationRespiratory Medicine, 1978